STEMLIFE BHD
(Bursa: 0137)

StemLife is the first stem cell banking and therapeutics company in Malaysia. Established in 2001 with blessings from the Malaysian Government, StemLife was awarded the prestigious MSC status in 2002, BioNexus Status in 2007 and on 17 October 2006 the company went for listing on the MESDAQ. As of 2008, StemLife is a fully licensed cord blood banking facility under the Private Healthcare Services & Facilities Act (PHFS Act), 1998, under the Ministry of Health Malaysia.StemLife is proud to be the first cord blood banking company in Malaysia to provide umbilical cord blood-derived stem cells.

0.565 S

- (-%)
Range 0.565 - 0.565   (-%)
Open 0.565
Previous Close 0.565
Bid Price -
Bid Volume ('00) -
Ask Price -
Ask Volume ('00) -
Volume ('00) -
Value -
Remark S
Delayed prices. Updated at 21 Feb 2017 06:05.
Data powered by
View All Events

Please login to view stock data and analysis